For research teamsHelp me find a study
Back to all studies
TerminatedNCT01363349

Safety study of CYP-1020 Compared to Risperidone in schizophrenia

This study was terminated in India, in Moldova, and in Romania. It is testing CYP-1020 Compared to Risperidone for schizophrenia.

Schizophrenia, Cognitive Effect on Schizophrenic PatientsDrugFrom 18 Years to 50 Years

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore recruiting studies on this topic

Then choose your country and confirm availability with each study site.

In plain English

Key information made simple

What is this study testing?

This study is testing whether BL-1020 Small Molecule may be useful for adults experiencing schizophrenia.

What would participation involve?

Participants may receive BL-1020 Small Molecule, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in India, in Moldova, and in Romania.

Who is it mainly for?

This study appears to be mainly for adults with schizophrenia.

What should you check before joining?

Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.

Your next step

Check the study details

Check the official source, then confirm these points with the research team.

View official study record (opens in a new tab)

  • Recruitment and eligibility

    Is a site open, and who can take part?

  • Visits and time

    Where are visits, can any be remote, and how much time is needed?

  • Costs and support

    What costs, reimbursement or compensation apply?

Before joining

Questions to ask before joining

Study clarity

Things to check before joining

Study start dateMay 2011
Recruitment status
Terminated
Enrollment listed in the registry
269
Sponsor
BioLineRx, Ltd.
Sponsor type
Other organization
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2, Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
India, Moldova, Romania
Age range
From 18 Years to 50 Years
Official registry ID
NCT01363349
Official title
A Randomized, Double-Blind, Active-Controlled,Phase 2/3 Study to Determine the Short-Term (6-Week) and Long-Term (6 Month) Cognitive and Anti-Psychotic Efficacy, Safety and Tolerability of CYP-1020 Compared to Risperidone in Patients With Schizophrenia

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT01363349. We help you review the study, but cannot decide medical eligibility.

Check recruitment and locations

Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.

View official study record (opens in a new tab)

The overall study status can differ from each site's status. Open a country to see its locations and their registry status.

India · 18 sites
  • Department of Psychiatry, Sheath VS General Hospital, Sheath KM School of Post Graduate Medicine & Research
    Ahmedabad
    Site status: Not listed — confirm with the team
  • Saoji Tupkari Hospital
    Aurangabad
    Site status: Not listed — confirm with the team
  • Spandana Nursing Home
    Bangalore
    Site status: Not listed — confirm with the team
  • KHM Hospital
    Chennai
    Site status: Not listed — confirm with the team
  • Asha Hospital
    Hyderabad
    Site status: Not listed — confirm with the team
  • Department of Psychiatry, Owaisi Hospital & Research Centre
    Hyderabad
    Site status: Not listed — confirm with the team
  • RK Yadav Memorial Mental Health and De-addiction Hospital
    Jaipur
    Site status: Not listed — confirm with the team
  • Mahendru Psychiatric Centre
    Kanpur
    Site status: Not listed — confirm with the team
  • Dreamland Nursing Home
    Kolkata
    Site status: Not listed — confirm with the team
  • Dayanand Medical College & Hospital
    Ludhiana
    Site status: Not listed — confirm with the team
  • Centre for Psychiatric Research, Department of Psychiatry, K.S Hegde Medical Academy
    Mangalore
    Site status: Not listed — confirm with the team
  • Jaslok Hospital&Research Centre
    Mumbai
    Site status: Not listed — confirm with the team
  • JSS Medical College Hospital
    Mysore
    Site status: Not listed — confirm with the team
  • Sujata Birla Hospital
    Nashik
    Site status: Not listed — confirm with the team
  • Vimhans Hospital
    New Delhi
    Site status: Not listed — confirm with the team
  • S.V.Medical College
    Tirupati
    Site status: Not listed — confirm with the team
  • Deva Mental Health Care
    Varanasi
    Site status: Not listed — confirm with the team
  • Vijayawada Institute of Mental Health & Neurosciences
    Vijayawada
    Site status: Not listed — confirm with the team
Moldova · 3 sites
  • IMSP Spitalul Clinic de Psihiatrie, Sectia 14
    Chisinau
    Site status: Not listed — confirm with the team
  • IMSP Spitalul Clinic de Psihiatrie, Sectia 17
    Chisinau
    Site status: Not listed — confirm with the team
  • IMSP Spitalul Clinic de Psihiatrie, Sectia 8
    Chisinau
    Site status: Not listed — confirm with the team
Romania · 18 sites
  • pitalul Clinic Judetean de Urgenta Arad Clinica Psihiatrie
    Arad
    Site status: Not listed — confirm with the team
  • Spitalul de Psihiatrie si Neurologie Brasov
    Brasov
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Psihiatrie "Prof. Dr. Al. Obregia"
    Bucharest
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Psihiatrie Dr. Alexandru Obregia Department 13
    Bucharest
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Psihiatrie Dr. Alexandru Obregia Department 1
    Bucharest
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Psihiatrie Dr. Alexandru Obregia Department 8
    Bucharest
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Psihiatrie Dr. Alexandru Obregia Department 9
    Bucharest
    Site status: Not listed — confirm with the team
  • Spitalul de Psihiatrie C.E.T.T.T. "Sf. Stelian"
    Bucharest
    Site status: Not listed — confirm with the team
  • Spitalul Judetean Cluj Napoca
    Cluj-Napoca
    Site status: Not listed — confirm with the team
  • Spitalul Clinic Judetean de Urgenta Constanţa Clinica de Psihiatrie
    Constanța
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Neuropsihiatrie Clinica de Psihiatrie nr. 2
    Craiova
    Site status: Not listed — confirm with the team
  • Spitalul de Neuropsihiatrie Clinica de Psihiatrie I
    Craiova
    Site status: Not listed — confirm with the team
  • Spitalul Clinic de Psihiatrie Socola
    Iași
    Site status: Not listed — confirm with the team
  • Spital Clinic de Neurologie si Psihiatrie Oradea
    Oradea
    Site status: Not listed — confirm with the team
  • Spitalul Clinic Municipal "Dr.Gavril Curteanu" Oradea
    Oradea
    Site status: Not listed — confirm with the team
  • Spitalul de Psihiatrie "Dr. Gh. Preda"
    Sibiu
    Site status: Not listed — confirm with the team
  • Spitalul Judetean de Urgenta Targoviste Clinica Psihiatrie Adulti nr. 7
    Targoviste
    Site status: Not listed — confirm with the team
  • Spitalul Clinic Judetean Mures, Clinica Psihiatrie Nr. 2
    Târgu Mureş
    Site status: Not listed — confirm with the team
In practice

For you

Participation may contribute to research. Personal benefit is not guaranteed.

Ask the research team to explain the activities, time commitment, and follow-up involved.

Study sites are listed. Confirm the relevant site and any travel before making plans.

Important

Not medical advice

Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com

FAQ

Questions about this study

What is this study trying to understand?

This study is exploring medication or study treatment for people with schizophrenia. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.

Does this study involve a medication?

This appears to be a medication / drug study involving CYP-1020, Risperidone. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.

Who might this study be for?

This study may concern people with schizophrenia; age range: From 18 Years to 50 Years. The criteria appear fairly broad, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.

What would I likely need to do?

You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.

What side effects, interactions, or treatment changes should I check?

If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.

Will I need to travel or attend in-person visits?

The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.

Who is behind this study?

This study is sponsored by BioLineRx, Ltd., which appears to be another type of organization. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.

Can I still join this study?

The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.